Medtronic (MDT) Return on Capital Employed (2015 - 2026)

Medtronic has disclosed Return on Capital Employed across 12 years of filings, most recently posting 7.36% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 7.36%, up 23.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 7.36% (up 23.0% YoY), and the FY2025 annual result was 7.64%, up 118.0% from the prior year.
• Return on Capital Employed came in at 7.36% for Q1 2026 at Medtronic, down from 7.65% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 7.88% in Q3 2022 to a low of 6.46% in Q2 2024.
• The 5-year median for Return on Capital Employed is 7.05% (2023), against an average of 7.14%.
• Across the five-year window, Return on Capital Employed soared 306 bps in 2022 and tumbled 100 bps in 2023, its largest moves.
• Medtronic's Return on Capital Employed stood at 7.6% in 2022, then retreated by 9 bps to 6.89% in 2023, then grew by 1 bps to 6.96% in 2024, then grew by 10 bps to 7.65% in 2025, then decreased by 4 bps to 7.36% in 2026.
• The last three Return on Capital Employed figures came in at 7.36% (Q1 2026), 7.65% (Q4 2025), and 7.67% (Q3 2025), per Business Quant data.